CHINA PHARMA HOLDINGS, INC. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/60957438-491d-4f00-b6f1-07b62c336b7b/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-3.2M | 2025-01-01 – 2025-12-31 | evidence 0001213900-26-038521 |
| FY 2024 | $-4.7M | 2024-01-01 – 2024-12-31 | evidence 0001213900-25-026280 |
| FY 2023 | $-3.1M | 2023-01-01 – 2023-12-31 | evidence 0001213900-24-028731 |
| FY 2022 | $-4.0M | 2022-01-01 – 2022-12-31 | evidence 0001213900-23-024710 |
| FY 2021 | $-3.4M | 2021-01-01 – 2021-12-31 | evidence 0001213900-22-016151 |
| FY 2020 | $-2.9M | 2020-01-01 – 2020-12-31 | evidence 0001213900-21-017981 |
| FY 2019 | $-20.7M | 2019-01-01 – 2019-12-31 | evidence 0001213900-20-008020 |
| FY 2018 | $-10.8M | 2018-01-01 – 2018-12-31 | evidence 0001213900-19-005094 |
| FY 2017 | $-19.3M | 2017-01-01 – 2017-12-31 | evidence 0001213900-18-003895 |
| FY 2016 | $-9.2M | 2016-01-01 – 2016-12-31 | evidence 0001010549-17-000112 |
| FY 2015 | $-15.4M | 2015-01-01 – 2015-12-31 | evidence 0001010549-16-000541 |
| FY 2014 | $-39.6M | 2014-01-01 – 2014-12-31 | evidence 0001010549-15-000416 |
| FY 2013 | $-20.0M | 2013-01-01 – 2013-12-31 | evidence 0001010549-14-000114 |
| FY 2012 | $4.6M | 2012-01-01 – 2012-12-31 | evidence 0001010549-13-000144 |
| FY 2011 | $19.3M | 2011-01-01 – 2011-12-31 | evidence 0001010549-12-000255 |
| FY 2010 | $23.4M | 2010-01-01 – 2010-12-31 | evidence 0001010549-12-000255 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CHINA PHARMA HOLDINGS, INC. — all facts · Revenue · Operating Income